Abstract
BackgroundGingival enlargement due to calcium channel blockers is a common complaint reported by patients. It can be localized or generalized and can range from mild to severe, affecting patients appearance and function. Nifedipine induced gingival enlargement is noticed only in 10 % of patients and very few cases of Nifedipine induced gingival enlargement in an edentulous patient have been documented in the literature.Case presentationHere in, we report a case of gingival enlargement in a 70 year old hypertensive edentulous patient who was on low dose Nifedipine therapy. Patient wanted complete dentures. We planned to excise the overgrowth and followed up for 1 year.ConclusionNifedipine induced gingival enlargement noticed only in 10 % of patients. Hence, there is a need for physicians and dentist to make a coordinated treatment plan and practice care while prescribing these drugs which are associated with gingival overgrowth.
Highlights
Gingival enlargement due to calcium channel blockers is a common complaint reported by patients
There is a need for physicians and dentist to make a coordinated treatment plan and practice care while prescribing these drugs which are associated with gingival overgrowth
Gingival hyperplasia is a multifactorial disease and drug induced gingival hyperplasia is an esthetically disfiguring over growth attributable to various medications [1, 2]
Summary
Gingival enlargement due to calcium channel blockers is a common complaint reported by patients. Conclusion: Nifedipine induced gingival enlargement noticed only in 10 % of patients. Gingival hyperplasia on long term use of Nifedipine is rare in the literature [3]. The first documented case of Nifedipine induced gingival enlargement was reported in 1984 [4].Clinically-evident overgrowth of gingiva can be seen within 1–2 months after initiation of therapy.
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
